Talquetamab & STOP-CA
Aug 10, 2023•15 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Talquetamab is approved for r/r multiple myeloma and the STOP-CA trials asks if atorvastatin can prevent anthracycline cardiotoxicity.
STOP-CA: https://jamanetwork.com/journals/jama/fullarticle/2807988
For the best experience, listen in Metacast app for iOS or Android